|
"lin zhong zhe"的相關文件
顯示項目 1-25 / 58 (共3頁)
1 2 3 > >>
每頁顯示[10|25|50]項目
| 臺大學術典藏 |
2022-01-14T03:38:07Z |
A Multicenter Phase II Study of Second-Line Axitinib for Patients with Advanced Hepatocellular Carcinoma Failing First-Line Sorafenib Monotherapy
|
Lin, Zhong-Zhe; Chen, Bang-Bin; Hung, Yi-Ping; HUANG, PO-HSIANG; Shen, Ying-Chun; Shao, Yu-Yun; Hsu, Chih-Hung; Cheng, Ann-Lii; Lee, Rheun-Chuan; Chao, Yee; Chiun Hsu |
| 國立臺灣大學 |
2006 |
A Phase Ii Study of Gefitinib as First Line Treatment for Good Performance Advanced or Metastatic Non-Small Cell Lung Cancer in East Asian Patients
|
楊志新; 余忠仁; 陳焜結; 林宗哲; 郭頌鑫; 鄭安理; 楊泮池; YANG, CHIH-HSIN; YU, CHONG-JEN; CHEN, KUN-CHIEH; LIN, ZHONG-ZHE; KUO, SUNG-HSIN; CHENG, ANN-LII; YANG, PAN-CHYR |
| 國立臺灣大學 |
2013 |
A pilot study of hepatic arterial infusion of chemotherapy for patients with advanced hepatocellular carcinoma who have failed anti-angiogenic therapy
|
Shao, Yu-Yun; Liang, Po-Chin; Wu, Yao-Ming; Huang, Chun-Chieh; Huang, Kai-Wen; Cheng, Jason C.; Hsu, Chih-Hung; Hsu, Chiun; Cheng, Ann-Lii; Lin, Zhong-Zhe; 邵幼雲; 林宗哲; 鄭安理; 成佳憲; 黃凱文; 徐志宏; 許駿; 梁博欽; 吳耀銘 |
| 臺大學術典藏 |
2022-03-14T23:44:59Z |
Association of annexin A10 expression with poor prognosis of intrahepatic cholangiocarcinoma
|
YU-YUN SHAO; HUNG-YANG KUO; YUNG-MING JENG; YAO-MING WU; HSIU-PO WANG; CHIUN HSU; CHIH-HUNG HSU; Hsu, Hey Chi; ANN-LII CHENG; Lin, Zhong Zhe |
| 臺大學術典藏 |
2022-04-14T07:44:52Z |
Association of annexin A10 expression with poor prognosis of intrahepatic cholangiocarcinoma
|
Shao, Yu-Yun; Kuo, Hung-Yang; Jeng, Yung-Ming; YAO-MING WU; Wang, Hsiu-Po; CHIUN HSU; CHIH-HUNG HSU; Hsu, Hey-Chi; Cheng, Ann-Lii; Lin, Zhong-Zhe |
| 國立臺灣大學 |
2013 |
Association of diabetes mellitus with increased mortality in patients receiving curative surgery for colon cancer
|
Chen, Kuo-Hsing; Shao, Yu Yun; Yeh, Yi-Chun; Shau, Wen-Yi; Kuo, Raymond Nienchen; Lin, Zhong-Zhe; Chen, Ho-Min; Yeh, Kun-Huei; Cheng, Ann-Lii; Lai, Mei-Shu; 邵幼雲; 賴美淑; 林宗哲; 鄭安理; 葉坤輝; 郭年真 |
| 臺大學術典藏 |
2019-03-04T06:50:19Z |
Clinical outcomes and secondary epidermal growth factor receptor (EGFR) T790M mutation among first-line gefitinib, erlotinib and afatinib-treated non-small cell lung cancer patients with activating EGFR mutations
|
Yang, James Chih Hsin;Lin, Zhong Zhe;Lee, Jih Hsiang;Yang, Ching Yao;Lin, Yen Ting;Chen, Kuan-Yu;CHONG-JEN YU;JIN-YUAN SHIH;CHIA-LIN HSU;CHAO-CHI HO;WEI-YU LIAO;JIN-SHING CHEN; Lin, Yen Ting; JIN-SHING CHEN; WEI-YU LIAO; CHAO-CHI HO; CHIA-LIN HSU; Yang, Ching Yao; Chen, Kuan-Yu; Lee, Jih Hsiang; Lin, Zhong Zhe; JIN-YUAN SHIH; Yang, James Chih Hsin; Chong-Jen Yu |
| 國立臺灣大學 |
2015 |
Comparative Effectiveness of First-Line Platinum-Based Chemotherapy Regimens for Advanced Lung Squamous Cell Carcinoma
|
Liao, Bin-Chi; Shao, Yu-Yun; Chen, Ho-Min; Shau, Wen-Yi; Lin, Zhong-Zhe; Kuo, Raymond Nienchen; Lai, Chiu-Ling; Chen, Kuo-Hsing; Cheng, Ann-Lii; Yang, James Chih-Hsin; Lai, Mei-Shu; 楊志新; 邵幼雲; 廖斌志; 賴美淑; 林宗哲; 鄭安理; 郭年真; 陳國興 |
| 國立臺灣大學 |
2013 |
Comparison of gefitinib and erlotinib efficacies as third-line therapy for advanced non-small-cell lung cancer
|
Shao, Yu-Yun; Shau, Wen-Yi; Lin, Zhong-Zhe; Chen, Ho-Min; Kuo, Raymond; Yang, James Chih-Hsin; Lai, Mei-Shu; 楊志新; 邵幼雲; 賴美淑; 林宗哲 |
| 臺大學術典藏 |
2020-04-09T09:34:35Z |
Considerations of heterogeneity in clinical trials for hepatocellular carcinoma
|
Cheng, Ann Lii;Hsu, Chih Hung;Lin, Zhong Zhe;Hsu, Chiun;Shen, Ying Chun;Lu, Li Chun;Shao, Yu Yun;Liu, Tsung Hao; Liu, Tsung Hao; Shao, Yu Yun; Lu, Li Chun; Shen, Ying Chun; Hsu, Chiun; Lin, Zhong Zhe; Hsu, Chih Hung; Cheng, Ann Lii |
| 國立臺灣大學 |
2014 |
Development of GADD45 beta (growth arrest DNA damage-inducible gene 45 beta) agonists for the treatment of hepatocellular carcinoma (HCC)
|
Hsu, Chiun; Ou, Da-Liang; Chen, Kuen-Feng; Lin, Zhong-Zhe; Cheng, Ann-Lii; Shiau, Chung-Wai; 林宗哲; 鄭安理; 許駿; 陳昆鋒; 歐大諒 |
| 國立臺灣大學 |
2012 |
Diabetes Mellitus Is Associated with Increased Mortality in Patients Receiving Curative Therapy for Hepatocellular Carcinoma
|
Shau, Wen-Yi; Shao, Yu-Yun; Yeh, Yi-Chun; Lin, Zhong-Zhe; Kuo, Raymond; Hsu, Chih-Hung; Hsu, Chiun; Cheng, Ann-Lii; Lai, Mei-Shu; 邵幼雲; 賴美淑; 林宗哲; 鄭安理; 徐志宏; 許駿 |
| 臺大學術典藏 |
2021-08-15T00:08:05Z |
Dynamic contrast-enhanced and intravoxel incoherent motion mri biomarkers are correlated to survival outcome in advanced hepatocellular carcinoma
|
BANG-BIN CHEN; YU-YUN SHAO; Lin, Zhong Zhe; CHIH-HUNG HSU; ANN-LII CHENG; CHIUN HSU; PO-CHIN LIANG; TIFFANY TING-FANG SHIH |
| 臺大學術典藏 |
2021-12-16T02:10:26Z |
Dynamic Contrast-Enhanced and Intravoxel Incoherent Motion MRI Biomarkers Are Correlated to Survival Outcome in Advanced Hepatocellular Carcinoma
|
BANG-BIN CHEN; Shao, Yu-Yun; Lin, Zhong-Zhe; Hsu, Chih-Hung; Cheng, Ann-Lii; CHIUN HSU; Liang, Po-Chin; Shih, Tiffany Ting-Fang |
| 臺大學術典藏 |
2021-12-16T03:39:19Z |
Dynamic Contrast-Enhanced and Intravoxel Incoherent Motion MRI Biomarkers Are Correlated to Survival Outcome in Advanced Hepatocellular Carcinoma
|
Chen, Bang-Bin; Shao, Yu-Yun; Lin, Zhong-Zhe; Hsu, Chih-Hung; Cheng, Ann-Lii; CHIUN HSU; Liang, Po-Chin; TIFFANY TING-FANG SHIH |
| 臺大學術典藏 |
2021-12-15T07:39:40Z |
Dynamic Contrast-Enhanced and Intravoxel Incoherent Motion MRI Biomarkers Are Correlated to Survival Outcome in Advanced Hepatocellular Carcinoma
|
Chen, Bang-Bin; Shao, Yu-Yun; Lin, Zhong-Zhe; Hsu, Chih-Hung; Cheng, Ann-Lii; CHIUN HSU; PO-CHIN LIANG; Shih, Tiffany Ting-Fang |
| 臺大學術典藏 |
2021-12-16T02:03:28Z |
Early Changes in DCE-MRI Biomarkers May Predict Survival Outcomes in Patients with Advanced Hepatocellular Carcinoma after Sorafenib Failure: Two Prospective Phase II Trials
|
BANG-BIN CHEN; Lin, Zhong-Zhe; Shao, Yu-Yun; CHIUN HSU; Hsu, Chih-Hung; Cheng, Ann-Lii; Liang, Po-Chin; Shih, Tiffany Ting-Fang |
| 臺大學術典藏 |
2021-12-15T07:29:31Z |
Early Changes in DCE-MRI Biomarkers May Predict Survival Outcomes in Patients with Advanced Hepatocellular Carcinoma after Sorafenib Failure: Two Prospective Phase II Trials
|
Chen, Bang-Bin; Lin, Zhong-Zhe; Shao, Yu-Yun; CHIUN HSU; Hsu, Chih-Hung; Cheng, Ann-Lii; PO-CHIN LIANG; Shih, Tiffany Ting-Fang |
| 臺大學術典藏 |
2021-12-16T03:25:51Z |
Early Changes in DCE-MRI Biomarkers May Predict Survival Outcomes in Patients with Advanced Hepatocellular Carcinoma after Sorafenib Failure: Two Prospective Phase II Trials
|
Chen, Bang-Bin; Lin, Zhong-Zhe; Shao, Yu-Yun; CHIUN HSU; Hsu, Chih-Hung; Cheng, Ann-Lii; Liang, Po-Chin; TIFFANY TING-FANG SHIH |
| 國立臺灣大學 |
2007 |
Efficacy of a Novel Histone Deacetylase Inhibitor in Murine Models of Hepatocellular Carcinoma
|
盧彥伸; 林宗哲; 陳德蓉; 鄭安理; 陳慶士; LU, YEN-SHEN; LIN, ZHONG-ZHE; CHENG, TE-JUNG; CHENG, ANN-LII; CHEN, CHING-SHIH |
| 國立臺灣大學 |
2012 |
Efficacy, Safety, and Potential Biomarkers of Thalidomide plus Metronomic Chemotherapy for Advanced Hepatocellular Carcinoma
|
Shao, Yu-Yun; Lin, Zhong-Zhe; Hsu, Chiun; Lee, Kuan-Der; Hsiao, Chi-Huang; Lu, Yen-Shen; Huang, Chien-Chung; Shen, Yin-Chun; Hsu, Chih-Hung; Cheng, Ann-Lii; 盧彥伸; 邵幼雲; 林宗哲; 鄭安理; 徐志宏; 許駿 |
| 臺大學術典藏 |
2021-11-24T08:20:52Z |
Eg5 as a Prognostic Biomarker and Potential Therapeutic Target for Hepatocellular Carcinoma
|
Shao, Yu-Yun; Sun, Nai-Yun; Jeng, Yung-Ming; YAO-MING WU; CHIUN HSU; Hsu, Chih-Hung; Hsu, Hey-Chi; Cheng, Ann-Lii; Lin, Zhong-Zhe |
| 臺大學術典藏 |
2021-09-14T23:18:28Z |
Eg5 as a Prognostic Biomarker and Potential Therapeutic Target for Hepatocellular Carcinoma
|
YU-YUN SHAO; Sun, Nai Yun; YUNG-MING JENG; YAO-MING WU; CHIUN HSU; CHIH-HUNG HSU; Hsu, Hey Chi; ANN-LII CHENG; Lin, Zhong Zhe |
| 國立臺灣大學 |
2012 |
Factors Impacting Prognosis Prediction in BCLC Stage C and Child-Pugh Class A Hepatocellular Carcinoma Patients in Prospective Clinical Trials of Systemic Therapy
|
Lin, Zhong-Zhe; Hsu, Chiun; Hu, Fu-Chang; Shao, Yu-Yun; Chang, Dwan-Ying; Yang, Chih-Hsin; Hong, Ruey-Long; Hsu, Chih-Hung; Cheng, Ann-Lii; 楊志新; 邵幼雲; 林宗哲; 鄭安理; 徐志宏; 洪瑞隆; 許駿; 胡賦強; 張端瑩 |
| 國立成功大學 |
2008-10 |
High efficacy of erlotinib in Taiwanese NSCLC patients in an expanded access program study previously treated with chemotherapy
|
Perng, Reury-Perng; Yang, Chih-Hsin; Chen, Yuh-Min; Chang, Gee-Chen; Lin, Meng-Chih; Hsieh, Ruey-Kuen; Chu, Nei-Min; Lai, Ruay-Sheng; Su, Wu-Chou; Tsao, Chao-Jung; Hsia, Te-Chun; Chen, Hao-Cheng; Chen, Chih-Hung; Huang, Ming-Shyan; Wang, Jui-Long; Ho, Ming-Lin; Chung, Chih-Yuan; Yu, Chong-Jen; Chang, Wen-Cheng; Kuo, Han-Pin; Yu, Chih-Teng; Lin, Zhong-Zhe; Kao, Woei-Yau |
顯示項目 1-25 / 58 (共3頁)
1 2 3 > >>
每頁顯示[10|25|50]項目
|
